Conference Call with Investors and Analysts to be Held on December 17, 2018
Third Quarter 2018 and Year-to-Date 2018 Highlights
CHICAGO–(BUSINESS WIRE)–Cresco Labs, Inc. (CSE:CL) (“Cresco” or “the Company”) one of the largest vertically integrated multistate cannabis operators in the United States, today released its financial results for the third quarter and nine months ended September 30, 2018. All financial information presented in this release is in U.S. dollars, unless otherwise noted.
Subsequent to the end of third quarter 2018, the Company completed a business combination with Randsburg International Gold Corp. upon which its subordinate voting shares were approved for listing on the Canadian Securities Exchange (“CSE”) under the symbol “CL.” Cresco’s shares began trading on the CSE on Monday, December 3, 2018. The Company is in the process of receiving approval by FINRA to list on the OTC market in the U.S. and is currently trading under the symbol “CRLBF.” Concurrent with its public listing on the CSE, Cresco launched its new investors website at investors.crescolabs.com.
1 Revenue presented in the text herein is calculated net of excise taxes.
2 Pro forma revenue and adjusted EBITDA information reflect consolidated results of less than majority owned affiliates.
3 See “Non-IFRS Financial Measures” at the end of this press release for more information regarding Cresco Labs’ use of non-IFRS financial measures.
“As one of the early cannabis companies to establish a national geographic footprint with substantial population reach and production capacity, Cresco is leading the way in normalizing and professionalizing our industry,” said Charles Bachtell, Co-founder and CEO of Cresco Labs. “As a multi-state operator (“MSO”), we have repeatedly proven our ability to get access to markets, get operational, get product to markets, and get disproportionate market share. Early on in our formation, we realized that cannabis is a natural fit within consumer-packaged goods (“CPG”) – an industry that requires consistency, reliability and availability. We therefore developed a unique and sophisticated ‘house of brands’ that addresses each major market segment and covers all price points. In essence, we developed a disciplined business blueprint that enables our rapid entry into regulated markets, where operator obligations are stringent, where our products can be accessible to customers, and where we can capture leading market share right from the start.
“Through our differentiated business approach, we have already proven that our capital starts working immediately to the benefit of our shareholders, regulators, legislators and consumers,” Bachtell continued. “Now, with increased access to the capital markets through our public listing, we can take our expansion strategy to the next level. We believe that Cresco has built the foundation needed to generate strong growth and attractive shareholder returns in the years ahead.”
Financial Results for the Third Quarter Ended September 30, 2018
Revenue for the third quarter of 2018 was $12.2 million, an increase of 335% compared to revenue of $2.8 million for the third quarter of 2017. The increase in revenue was driven by market expansion and gains in market share in the states where the Company operates. Third quarter revenue increased 51% compared to $8.1 million for the second quarter of 2018.
On a pro forma basis, revenue for the third quarter was $16.3 million compared to $11.8 million for the second quarter of 2018, an increase of 39%.
Third quarter gross profit, before the gain from biological assets, was $5.4 million, or 45% of revenues, compared to less than $0.1 million, or 1% of revenues, for the third quarter of 2017 and $3.5 million, or 43% of revenues, for the second quarter of 2018.
Net income for the third quarter was $3.9 million, compared to net loss of $0.2 million for the prior-year period. Net income nearly doubled from $2.0 million for the second quarter of 2018.
Adjusted EBITDA for the third quarter was $5.3 million, compared to less than $0.1 million for the third quarter of 2017 and $2.1 million for the second quarter of 2018. Pro forma adjusted EBITDA was $5.9 million for the third quarter and $2.7 million for the second quarter of 2018.
Balance Sheet and Liquidity
As of September 30, 2018, the Company had total assets of $149.5 million, including cash and cash equivalents of $93.9 million, which does not reflect the full amount of proceeds from financing activities completed subsequent to the end of the quarter. Long-term liabilities totaled $2.0 million. At September 30, 2018, the Company had a working capital position of $105.3 million.
Subsequent to the end of the third quarter of 2018, the Company increased its liquidity through additional capital raises:
Awards and Recognition
A core principle of the Company is to build a team of subject matter experts to propel Cresco’s growth in every vertical of the business. Recent hires include:
In addition to the above key hires, Cresco has recruited experts across every industry from companies including Stericycle, Abbvie, Abbott, Cushman & Wakefield, Pandora and BMO Financial Group.
Conference Call and Webcast
The Company will hold a conference call and webcast to discuss its business and financial results next Monday, December 17, 2018 at 5 p.m. Eastern Time (4 p.m. Central Time). The conference call may be accessed via Cresco Labs’ investors website at investors.crescolabs.com or by dialing 866-688-4235 (409-216-0711 for international callers) and entering conference ID 5047018. Archived access to the webcast will be available for one year on Cresco’s investors website.
Consolidated Financial Statements
The Company’s unaudited consolidated interim financial statements and accompanying notes for the third quarter 2018 are available under the Company’s profile on SEDAR at www.sedar.com and on Cresco’s investors website at investors.crescolabs.com.
Cresco references certain non-IFRS financial measures throughout this press release, which may not be comparable to similar measures presented by other issuers. Please see the “Non-IFRS Financial Measures” section at the end of this press release for more detailed information.
About Cresco Labs, Inc.
Cresco Labs, based in Chicago, is a leading U.S. cannabis company with experienced management, access to capital and a demonstrated growth strategy. As a differentiated grower, processor and retailer of premium cannabis operating in seven states, the company focuses on entering highly regulated markets with outsized demand potential and high barriers to entry. Its impressive speed-to-market gives Cresco a distinct competitive advantage as it replicates its model to expand its national footprint. Cresco’s proven ability to execute is complemented by a cutting-edge brand strategy spearheaded by several of the brightest minds in consumer marketing in the nation. Cresco’s products are tailored to all major consumer segments: everyday cannabis, medicinally focused, connoisseur grade, and chef inspired edibles by James Beard Award-winning pastry chef Mindy Segal. Learn more about Cresco Labs at crescolabs.com.
Non-IFRS Financial Measures
EBITDA and Adjusted EBITDA are non-IFRS measures and do not have standardized definitions under IFRS. The following information provides reconciliations of the supplemental non-IFRS financial measures, presented herein to the most directly comparable financial measures calculated and presented in accordance with IFRS. The Company has provided the non-IFRS financial measures, which are not calculated or presented in accordance with IFRS, as supplemental information and in addition to the financial measures that are calculated and presented in accordance with IFRS. These supplemental non-IFRS financial measures are presented because management has evaluated the financial results both including and excluding the adjusted items and believe that the supplemental non-IFRS financial measures presented provide additional perspective and insights when analyzing the core operating performance of the business. These supplemental non-IFRS financial measures should not be considered superior to, as a substitute for or as an alternative to, and should only be considered in conjunction with, the IFRS financial measures presented herein.
Forward Looking Statements
This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as, ‘may,’ ‘will,’ ‘should,’ ‘could,’ ‘would,’ ‘expects,’ ‘plans,’ ‘anticipates,’ ‘believes,’ ‘estimates,’ ‘projects,’ ‘predicts,’ ‘potential’ or ‘continue’ or the negative of those forms or other comparable terms. The Company’s forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including but not limited to those risks discussed under “Risk Factors” in the company’s CSE Listing Statement filed with SEDAR; and other factors, many of which are beyond the control of the Company. Readers are cautioned that the foregoing list of factors is not exhaustive. Because of these uncertainties, you should not place undue reliance on the Company’s forward-looking statements. No assurances are given as to the future trading price or trading volumes of Cresco’s shares, nor as to the Company’s financial performance in future financial periods. The Company does not intend to update any of these factors or to publicly announce the result of any revisions to any of the Company’s forward-looking statements contained herein, whether as a result of new information, any future event or otherwise. Except as otherwise indicated, this press release speaks as of the date hereof. The distribution of this press release does not imply that there has been no change in the affairs of the Company after the date hereof or create any duty or commitment to update or supplement any information provided in this press release or otherwise.
Your email address will not be published. Required fields are marked *
Save my name, email, and website in this browser for the next time I comment.
Notify me of follow-up comments by email.
Notify me of new posts by email.
PRESS RELEASE The combination of the two companies will expand Pipp’s position as the leading provider of Indoor Commercial Grow Racks, Greenhouse Structures and Air Circulation Systems in North America. Walker, Michigan – October 18, 2021 – Pipp…
The state’s adult-use cannabis industry brought in nearly $60 million in its first year, but some fear market saturation and mega-competitors from out of state. One year after Maine launched its legal adult-use cannabis market, industry members say they’re encouraged by the market’s rapid growth, but they also shared worries about the possibility of market…
Trends in Cannabis Legalization While employers in the transportation industry are acutely aware of the effects COVID-19 has imposed over the last 18 months, another phenomenon has been making itself known: the ever-increasing tally of states and localities across the country legalizing cannabis for medicinal and recreational purposes. A majority of states now have enacted…
CALLS by the leaders of two German police unions for politicians to U-Turn on the their progressive march towards cannabis legalisation have been roundly condemned. This comes as political talks continue towards the the formation of a cannabis-friendly ‘Traffic-Light Coalition’. It appears that it is just these talks – and the potential for adult-use legalisation…